Skip to main content
. 2020 Nov 6;8:596658. doi: 10.3389/fchem.2020.596658

Figure 3.

Figure 3

(A) Schematic illustration of fabrication and mechanism of UCMSs-MC540-TF nanovaccines for PDT and immunotherapy. (B) Flow cytometric analyses of the populations of CD4+ (CD3+ CD4+ as the marker) and CD8+ (CD3+ CD8+ as the marker) T cells in splenocytes of mice immunized by various vaccine formulation. (C) The populations of CD4+ after different treatments. (D) The populations of CD8+ after different treatments. Copyright 2018, Wiley-VCH (Ding et al., 2018). *P < 0.5, **P < 0.01, ***P < 0.001.